Literature DB >> 18256157

The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.

Kristin M Bedard1, Michael P Underbrink, Heather L Howie, Denise A Galloway.   

Abstract

Human papillomaviruses (HPVs) belonging to the Betapapillomavirus genus have recently been implicated in squamous cell carcinomas of the skin, though the mechanisms by which they initiate carcinogenesis are unclear. We show that human foreskin keratinocytes (HFKs) expressing several betapapillomavirus E6 (beta-E6) proteins display life span extension, but not to the extent seen in HFKs expressing HPV type 16 E6 (16E6). Additionally, we demonstrate that beta-E6 proteins can differentially activate telomerase. HFKs expressing 38E6 exhibit significant telomerase activity but to a lesser degree than that observed with 16E6; however, other beta-E6 proteins, including 5E6, 8E6, 20E6, and 22E6, exhibit low or background levels of telomerase activity. Utilizing glutathione S-transferase pull-down and coimmunoprecipitation experiments, the beta-E6 proteins were shown to interact with the cellular proteins E6-associated protein (E6AP) and NFX1-91, two proteins known to be important for telomerase activation by 16E6. Interestingly, the relative strength of the interaction between E6 and E6AP or NFX1-91 was proportionate to the activation of telomerase by each beta-E6 protein. To address the requirement for E6AP in telomerase activation by beta-E6 proteins, we utilized a shRNA to knock down endogenous levels of E6AP. Lysates with decreased levels of E6AP showed a reduced ability to activate telomerase, suggesting that E6AP is a necessary component. These data suggest that complex formation between E6, E6AP, and NFX1-91 is a critical step in mediating telomerase activation, which may be one contributing factor to cellular life span extension during human betapapillomavirus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256157      PMCID: PMC2292992          DOI: 10.1128/JVI.01818-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.

Authors:  Mary C Thomas; Cheng-Ming Chiang
Journal:  Mol Cell       Date:  2005-01-21       Impact factor: 17.970

2.  The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.

Authors:  H Stöppler; D P Hartmann; L Sherman; R Schlegel
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

3.  Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells.

Authors:  A J Klingelhutz; S A Barber; P P Smith; K Dyer; J K McDougall
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

4.  Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.

Authors:  S R Bartz; M A Vodicka
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

5.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

6.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

Authors:  S N Boyer; D E Wazer; V Band
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

7.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

Authors:  A Schmitt; J B Harry; B Rapp; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

10.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

Authors:  T Kiyono; S A Foster; J I Koop; J K McDougall; D A Galloway; A J Klingelhutz
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962

View more
  34 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 2.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

5.  HPV E6 protein interacts physically and functionally with the cellular telomerase complex.

Authors:  Xuefeng Liu; Aleksandra Dakic; Yiyu Zhang; Yuhai Dai; Renxiang Chen; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

6.  E6AP/UBE3A ubiquitin ligase harbors two E2~ubiquitin binding sites.

Authors:  Virginia P Ronchi; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

Review 7.  Human papillomaviruses: shared and distinct pathways for pathogenesis.

Authors:  Denise A Galloway; Laimonis A Laimins
Journal:  Curr Opin Virol       Date:  2015-09-20       Impact factor: 7.090

Review 8.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

9.  Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.

Authors:  Alessandra Handisurya; Ratish Gambhira; Christina Schellenbacher; Saeed Shafti-Keramat; Ola Forslund; Michel Favre; Reinhard Kirnbauer
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

Review 10.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.